APTIVUS vs VIREAD

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. APTIVUS and VIREAD are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	APTIVUS	VIREAD
Rating	72/100	72/100
Pharmacy pays	—	~$9.49 /30
Type	RX	RX
Active ingredient	TIPRANAVIR	TENOFOVIR DISOPROXIL FUMARATE
Manufacturer	Boehringer Ingelheim	Gilead Sciences Inc
Dosage forms	Capsule	Powder, Tablet
Drug class	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Boxed warning	None	Boxed warning
Treats	Acquired Immunodeficiency Syndrome	Chronic Hepatitis B, Acquired Immunodeficiency Syndrome

aptivus viread

Rating

72/100

Pharmacy pays

—

~$9.49 /30

Type

Active ingredient

TIPRANAVIR

TENOFOVIR DISOPROXIL FUMARATE

Manufacturer

Boehringer Ingelheim

Gilead Sciences Inc

Dosage forms

Capsule

Powder, Tablet

Drug class

—

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Boxed warning

None

Boxed warning

Treats

Acquired Immunodeficiency Syndrome

Chronic Hepatitis B, Acquired Immunodeficiency Syndrome

Frequently asked questions

Which is better-rated, Aptivus or Viread?

Aptivus and Viread are tied at 3.6 out of 5 by our independent rating.

What is the difference between Aptivus and Viread?

Aptivus contains Tipranavir, while Viread contains Tenofovir Disoproxil Fumarate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.